SCHEMBL36620

SCHEMBL36620

CC(C)=CCOCC=C(C)C

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
BTN3A1 O00481 1/20 0.41
KMT2A Q03164 3/20 0.35
ALOX15 P16050 3/20 0.34
ALDH1A1 P00352 2/20 0.34
NFE2L2 Q16236 1/20 0.32
MEN1 O00255 2/20 0.32
CYP3A4 P08684 2/20 0.32
MAPT P10636 2/20 0.31
NOS1 P29475 1/20 0.31
TSHR P16473 1/20 0.31
UGT1A1 P22309 1/20 0.31
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP9 P14780 1/20 0.31
MMP12 P39900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL20769297 0.91 BTN3A1 (0.37) BTN3A1KMT2AALOX15ALDH1A1MEN1
SCHEMBL7260848 0.87 BTN3A1 (0.38) BTN3A1KMT2AALOX15ALDH1A1NFE2L2
SCHEMBL6905712 0.86
SCHEMBL26679537 0.86
1,4-Butanediol SCHEMBL867063 0.86 SQLE (0.43) BTN3A1KMT2AALOX15ALDH1A1MEN1
SCHEMBL25405879 0.84 BTN3A1 (0.37) BTN3A1KMT2AALOX15ALDH1A1MEN1
SCHEMBL29048951 0.84
SCHEMBL294026 0.84
SCHEMBL29143185 0.84 BTN3A1 (0.33) BTN3A1KMT2AALOX15ALDH1A1MEN1
SCHEMBL425261 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1443 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3201154-B1 LOW-TO-MID-RANGE WATER REDUCTION USING POLYCARBOXYLATE COMB POLYMERS GCP APPLIED TECH INC (US) 2025-12-10 EP claimed
US-20250236633-A1 SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES Roche Sequencing Solutions, Inc. (US) 2025-07-24 US claimed
EP-4499655-A1 SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES F. Hoffmann-La Roche AG (CH) 2025-02-05 EP claimed
CN-117263780-B Preparation method of trimethylolpropane diallyl ether 深圳市普利凯新材料股份有限公司 2024-12-06 CN claimed
WO-2024200864-A1 METHOD FOR THE SYNTHETIC CLEANING OF PEPTIDES WITHOUT HPLC Technische Universität Berlin (DE) 2024-10-03 WO claimed
US-11920026-B2 Polymer, preparation method therefor, nanofiber synthesized therefrom, and method for fabricating same nanofiber i-CoreBio Inc. (KR) 2024-03-05 US claimed
EP-3770208-B1 METHOD FOR DECOLORIZING A COLORED SYNTHETIC OR NON-SYNTHETIC POLAR-POLYMER MATERIAL SMART COLORING GMBH (DE) 2024-02-07 EP claimed
US-20240034855-A1 COMPOSITIONS COMPRISING A GRAPHENE-BASED MATERIAL AS LUBRICANT ADDITIVES EVONIK OPERATIONS GMBH (DE) 2024-02-01 US claimed
CN-117263780-A Preparation method of trimethylolpropane diallyl ether 深圳市普利凯新材料股份有限公司 2023-12-22 CN claimed
WO-2023186842-A1 SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES F. HOFFMANN-LA ROCHE AG (CH) 2023-10-05 WO claimed
US-20030099782-A1 Method for the production of coatings, adhesive layers or seals for primed or unprimed substrates BASF AKTIENGESELLSCHAFT (DE) 2003-05-29 US claimed
US-20030091833-A1 Substance mixture which can be cured thermally and by using actinic radiation,and the use thereof BASF COATINGS AKTIENGESELLSCHAFT (DE) 2003-05-15 US claimed
US-20030036604-A1 Method for producing coatings from coating materials, which can be cured thermally and by using actinic radiation BASF COATINGS AKTIENGESELLSCHAFT (DE) 2003-02-20 US claimed
US-20020198314-A1 Powder slurry and method for producing a coloured and or decorative effect multi layered coating on a primed or unprimed BASF COATINGS AKTIENGESELLSCHAFT (DE) 2002-12-26 US claimed
US-5348946-A Heteroanthracycline antitumor analogs BIOCHEM IMMUNOSYSTEMS, INC. (CA) 1994-09-20 US claimed
EP-0533744-A1 HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS BIOCHEM PHARMA INC. (CA) 1993-03-31 EP claimed
WO-1992015601-A2 HETEROANTHRACYCLINE ANTITUMOR ANALOGS BIOCHEM PHARMA, INC. (CA) 1992-09-17 WO claimed
EP-0502661-A2 Heteroanthracycline anti-tumor analogues BIOCHEM PHARMA INC. (CA) 1992-09-09 EP claimed
WO-1991019725-A2 HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS BIOCHEM PHARMA INC. (CA) 1991-12-26 WO claimed
US-4048426-A DIISOPRENYL ETHER IN BUTADIENE-STYRENE EMULSION PHILLIPS PETROLEUM COMPANY (US) 1977-09-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250236633-A1 SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES PARG, PPA1, PGM2 BTN3A1 4389/4885KMT2A 1439/4885ALOX15 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.